Winton Group LTD Intra Cellular Therapies, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $198,282 - $257,993	4,527 New	4,527 $245,000
Q4 2021 Feb 10, 2022	SELL	$35.2 - $53.42 $400,188 - $607,331	-11,369 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$28.72 - $42.49 $129,699 - $191,884	4,516 Added 65.9%	11,369 $424,000
Q2 2021 Aug 10, 2021	SELL	$29.3 - $44.5 $115,822 - $175,908	-3,953 Reduced 36.58%	6,853 $280,000
Q1 2021 Jul 21, 2021	BUY	$30.8 - $39.51 $332,824 - $426,945	10,806 New	10,806 $367,000

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.